Pay in 4 interest-free payments of $7.34 Learn more
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11
BPC-157 Side Effects: What the Research Literature Reports What the published in-vitro and animal-model literature reports about BPC-157 tolerability for laboratory documentation
A provider can help determine the most appropriate treatment.
It is a first-of-its-kind treatment for obesity, overweight, and type 2 diabetes that activates both GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) hormone receptors
Biohacker Protocol (experimental) Dose: 0.25 mg (= 10 clicks) Duration: Continuous Frequency: Twice daily Cycle Interval: No fixed interval / take 1 week off every 8 weeks Goal / Description: Micro-dosing approach focusing on steady fat metabolism
Whether you are targeting weight loss specifically or managing concurrent type 2 diabetes, we offer expert consultation to determine the most appropriate medication based on your health profile and goals
